Shukra Pharmaceuticals Ltd — Insider Trading, 23-12-2025: Insider Trading / SAST

The company has announced the closure of its trading window for designated persons, including promoters, directors, and their immediate relatives. This closure begins on January 1, 2026, and will remain in effect until 48 hours after the declaration of the financial results for the quarter ended December 31, 2025. This measure ensures fair trading practices and prevents insider trading ahead of key financial disclosures. The date of the board meeting to approve these results will be announced shortly.